A new animal model of (chronic) depression induced by repeated and intermittent lipopolysaccharide administration for 4months

Brain, Behavior, and Immunity

Volumn 31, Issue , 2013, Pages 96-104

  Kubera, Marta ^a   Curzytek, Katarzyna ^a   Duda, Weronika ^a   Leskiewicz, Monika ^a   Basta Kaim, Agnieszka ^a   Budziszewska, Boguslawa ^a,b   Roman, Adam ^a   Zajicova, Alena ^c   Holan, Vladimir ^c   Szczesny, Ewa ^a   Lason, Wladyslaw ^a,b   Maes, Michael ^d,e,f  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^d Piyavate Hospital   (Thailand)

^e CHULALONGKORN UNIVERSITY   (Thailand)

^f DEAKIN UNIVERSITY   (Australia)

Author keywords

Chronic depression; Cytokines; Inflammation; Leaky gut; LPS; Oxidative and nitrosative stress

Indexed keywords

CORTICOSTERONE; FLUOXETINE; GAMMA INTERFERON; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; SUCROSE; SUPEROXIDE; TOLL LIKE RECEPTOR 4;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CHRONIC DISEASE; COGNITION; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FEMALE; FLUID INTAKE; FOOD INTAKE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPLEEN CELL; THYMUS;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BODY WEIGHT; CHOICE BEHAVIOR; DEPRESSION; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; EATING; FEMALE; FLUOXETINE; LIPOPOLYSACCHARIDES; MICE; SUCROSE; THYMUS GLAND;

EID: 84878146364     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.01.001     Document Type: Article

References (71)

1. Azevedo R.B., Lacava Z.G., Miyasaka C.K., Chaves S.B., Curi R. Regulation of antioxidant enzyme activities in male and female rat macrophages by sex steroids. Braz. J. Med. Biol. Res. 2001, 34:683-687.
2. Balkhy H.H., Heinzel F.P. Endotoxin fails to induce IFN-gamma in endotoxin-tolerant mice. Deficiencies in both IL-12 heterodimer production and IL-12 responsiveness. J. Immunol. 1999, 162(6):3633-3638.
3. Berk M., Conus P., Lucas N., Hallam K., Malhi G.S., Dodd S., Yatham L.N., Yung A., McGorry P. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007, 9(7):671-678.
4. Berk M., Hallam K.T., McGorry P.D. The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J. Affect. Disord. 2007, 100(1-3):279-281.
5. Berlim M.T., Turecki G. What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur. Neuropsychopharmacol. 2007, 17(11):696-707.
6. Bilici M., Efe H., Köroglu M.A., Uydu H.A., Bekaroglu M., Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J. Affect. Disord. 2001, 64(1):43-51.
7. Bodet D., Glaize G., Dabadie M.P., Geffard M. Immunological follow-up for multiple slerosis. Immuno-Anal. Biol. Spec. 2004, 19:138-147.
8. Boland R.J., Keller M.B. The course of depression. Neuropsychopharmacology, the 5th Generation of Progress 2002, American College of Neuropsychopharmacology, New York. K.L. Davis, D. Charney, J.T. Coyle, C. Nemeroff (Eds.).
9. Boullerne A., Petry K.G., Geffard M. Circulating antibodies directed against conjugated fatty acids in sera of patients with multiple sclerosis. J. Neuroimmunol. 1996, 65(1):75-81.
10. Cavaillon J.M., Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit. Care 2006, 10(5):233.
11. Daverat P., Geffard M., Orgogozo J.M. Identification and characterization of anti-conjugated azelaic acid antibodies in multiple sclerosis. J. Neuroimmunol. 1989, 22(2):129-134.
12. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctôt K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67(5):446-457.
13. Draisma A., Pickkers P., Bouw M.P., Van der Hoeven J.G. Development of endotoxin tolerance in humans in vivo. Crit. Care Med. 2009, 37(4):1261-1267.
14. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 2000, 52:595-638.
15. Freire-Garabal M., Nunez M.J., Riveiro P., Balboa J., Lopez P., Zamorano G.B., Rodrigo E., Rey-Mendez M. Effects of fluoxetine on the activity of phagocytosis in stressed mice. Life Sci. 2002, 72:173-183.
16. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009, 71(2):171-186.
17. Irie M., Asami S., Ikeda M., Kasai H. Depressive state relates to female oxidative DNA damage via neutrophil activation. Biochem. Biophys. Res. Commun. 2003, 311(4):1014-1018.
18. Khanzode S.D., Dakhale G.N., Khanzode S.S., Saoji A., Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep. 2003, 8(6):365-370.
19. Kubera M., Maes M. Serotonin-immune interactions in major depression. Neuro-Immune Interactions in Neurologic and Psychiatric Disorders 2000, 79-87. Springer-Verlag, Berlin, Heidelberg. P. Petterson, C. Kordon, Y. Christen (Eds.).
20. Kubera M., Basta-Kaim A., Papp M. The effect of chronic treatment with imipramine on the immunoreactivity of animals subjected to a chronic mild stress model of depression. Immunopharmacology 1995, 30:225-230.
21. Kubera M., Holan V., Mathison R., Maes M. The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice. Psychoneuroendocrinology 2000, 25(8):785-797.
22. Kubera M., Simbirtsev A., Mathison R., Maes M. Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice. Psychiatry Res. 2000, 96(3):255-266.
23. Kubera M., Maes M., Holan V., Basta-Kaim A., Roman A., Shani J. Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. J. Affect. Disord. 2001, 63:171-178.
24. Kubera M., Lin A.H., Kenis G., Bosmans E., van Bockstaele D., Maes M. Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J. Clin. Psychopharmacol. 2001, 21(2):199-206.
25. Kubera M., Basta-Kaim A., Budziszewska B., Jaworska-Feil L., Lekiewicz M., Tetich M., Korzeniak B., Laso W. Immunoreactivity of C57BL/6 mice in, a new model of depression induced by intermittent repeated lipopolysaccharide (LPS) injection. Pol. J. Pharmacol 2004, 56:87.
26. Kubera, M., Roman, A., Basta-Kaim, A., Budziszewska, B., Jaworska-Feil, L., Lekiewicz, M., Korzeniak, B., Jagla, G., Nowak, W., Laso, W., 2006. The effect of fluoxetine on cytokine production in lipopolysaccharide treated C57BL/6 mice. In: 15th International Symposium " Molecular and Physiological Aspects of Regulatory Processes of the Organism" . Kraków 1-2.06.06. Materials, pp. 292-294.
27. Kubera M., Kreiner G., Detka J., Grygier B., Szczesny E., Dardzinska A., Glombik K., Basta-Kaim A., Budziszewska B., Leskiewicz M., Curzytek K., Roman A., Nalepa I., Lason W. Stimulatory effect of repeated fluoxetine treatment on IL-10 brain expression in young and old C57BL/6J mice subjected to LPS. J. Physiol. Pharmacol. 2011, 62(Suppl. 1):182.
28. Kubera M., Obuchowicz E., Goehler L., Brzeszcz J., Maes M. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(3):744-759.
29. Kwant A., Sakic B. Behavioral effects of infection with interferon-gamma adenovector. Behav. Brain Res. 2004, 151:73-82.
30. Lehner M.D., Hartung T. Endotoxin tolerance-mechanisms and beneficial effects in bacterial infection. Rev. Physiol. Biochem. Pharmacol. 2002, 44:95-141.
31. Leonard B., Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci. Biobehav. Rev. 2012, 36(2):764-785.
32. Li G., Sun S., Cao X., Zhong J., Tong E. LPS-induced degeneration of dopaminergic neurons of substantia nigra in rats. J. Huazhong Univ. Sci. Technol. Med. Sci. 2004, 24:83-86.
33. Li F.Q., Wang T., Pei Z., Liu B., Hong J.S. Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons. J. Neural. Transm. 2005, 112:331-347.
34. Liu Y., Ho R.C., Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-αa) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J. Affect. Disord. 2011, [Epub ahead of print] PubMed PMID: 21872339.
35. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(3):664-675.
36. Maes M., De Ruyter M., Hobin P., Suy E. Repeated dexamethasone suppression test in depressed patients. J. Affect. Disord. 1986, 11(2):165-172.
37. Maes M., Bosmans E., Suy E., Minner B., Raus J. Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process. Br. J. Psychiatry 1989, 155:793-798.
38. Maes M., Smith R., Scharpe S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 1995, 20:111-116.
39. Maes M., Christophe A., Delanghe J., Altamura C., Neels H., Meltzer H.Y. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999, 85(3):275-291.
40. Maes M., Song C., Lin A.H., Bonaccorso S., Kenis G., De Jongh R., Bosmans E., Scharpé S. Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 1999, 20(4):370-379.
41. Maes M., De Vos N., Pioli R., Demedts P., Wauters A., Neels H., Christophe A. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J. Affect. Disord. 2000, 58(3):241-246.
42. Maes M., Mihaylova I., Leunis J.C. Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuro Endocrinol. Lett. 2007, 28(6):861-867.
43. Maes M., Kubera M., Leunis J.C. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol. Lett. 2008, 29(1):117-124.
44. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E. Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease. J. Affect. Disord. 2010, 125(1-3):287-294.
45. Maes M., Galecki P., Chang Y.S., Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(3):676-692.
46. Maes M., Mihaylova I., Kubera M., Leunis J.C., Geffard M. IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: New pathways that underpin the inflammatory and neuroprogressive pathophysiology. J. Affect. Disord. 2011, 135(1-3):414-418.
47. Maes M., Berk M., Goehler L., Song C., Anderson G., Galecki P., Leonard B. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med. 2012, 10:66. PubMed PMID: 22747645; PubMed Central PMCID: PMC3391987.
48. Maes M., Kubera M., Leunis J.C., Berk M. Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J. Affect. Disord. 2012, [Epub ahead of print] PubMed PMID: 22410503.
49. Maes M., Song C., Yirmiya R. Targeting IL-1 in depression. Expert Opin. Ther. Targets. 2012, 16:1097-1112.
50. Maes, M., Kubera, M., Leunis, J.C., Berk, M., Geffard, M., in press. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS damaged neoepitopes. Acta Psychiatr. Scand.
51. Melo E.S., Barbeiro H.V., Ariga S., Goloubkova T., Curi R., Velasco I.T., Vasconcelos D., Soriano F.G. Immune cells and oxidative stress in the endotoxin tolerance mouse model. Braz. J. Med. Biol. Res. 2010, 43(1):57-67.
52. Mormède C., Palin K., Kelley K.W., Castanon N., Dantzer R. Conditioned taste aversion with lipopolysaccharide and peptidoglycan does not activate cytokine gene expression in the spleen and hypothalamus of mice. Brain Behav. Immun. 2004, 18(2):186-200.
53. Moylan S., Maes M., Wray N.R., Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol. Psychiatry 2012, [Epub ahead of print] PubMed PMID: 22525486. 10.1038/mp.2012.33.
54. Papp M., Moryl E., Willner P. Pharmacological validation of the chronic mild stress model of depression. Eur. J. Pharmacol. 1996, 296:129-136.
55. Parry B.L. Mood disorders linked to the reproductive cycle in women. Psychopharmacology: The Fourth Generation of Progress 1995, 1029-1042. Raven Press, New York. F.E. Bloom, D.J. Kupfer (Eds.).
56. Peet M., Murphy B., Shay J., Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol. Psychiatry 1998, 43(5):315-319.
57. Qin L., Liu Y., Wang T., Wie S.J., Block M.L., Wilson B., Liu B., Hong J.S. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J. Biol. Chem. 2004, 279:1415-1421.
58. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55(5):453-462.
59. Rogóz Z., Kubera M., Rogóz K., Basta-Kaim A., Budziszewska B. Effect of co-administration of fluoxetine and amantadine on immunoendocrine parameters in rats subjected to a forced swimming test. Pharmacol. Rep. 2009, 61(6):1050-1060.
60. Roman A., Rogóz Z., Kubera M., Nawrat D., Nalepa I. Concomitant administration of fluoxetine and amantadine modulates the activity of peritoneal macrophages of rats subjected to a forced swimming test. Pharmacol. Rep. 2009, 61(6):1069-1077.
61. Roque S., Correia-Neves M., Mesquita A.R., Palha J.A., Sousa N. Interleukin-10: a key cytokine in depression?. Cardiovasc. Psychiatry Neurol. 2009, 2009:187894.
62. Sachdeva A.K., Kuhad A., Tiwari V., Arora V., Chopra K. Protective effect of epigallocatechin gallate in murine water-immersion stress model of chronic fatigue syndrome. Basic Clin. Pharmacol. Toxicol. 2010, 106(6):490-496.
63. Saki B., Szechtman H., Braciak T., Richards C., Gauldie J., Denburg J.A. Reduced preference for sucrose in autoimmune mice. a possible role of interleukin-6. Brain Res. Bull. 1997, 44(2):155-165.
64. Saki B., Gauldie J., Denburg J.A., Szechtman H. Behavioral effects of infection with IL-6 adenovector. Brain Behav. Immun. 2001, 15(1):25-42.
65. Shen Y., Connor T.J., Nolan Y., Kelly J.P., Leonard B.E. Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sci. 1999, 65:1773-1786.
66. Swiergiel A.H., Dunn A.J. Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol. Biochem. Behav. 2007, 86(4):651-659.
67. Szewczyk B., Kubera M., Nowak G. The role of zinc in neurodegenerative inflammatory pathways in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(3):693-701.
68. Taylor G.T., Farr S., Klinga K., Weiss J. Chronic fluoxetine suppresses circulating estrogen and the enhanced spatial learning of estrogen-treated ovariectomized rats. Psychoneuroendocrinology 2004, 29:1241-1249.
69. Tonelli L.H., Holmes A., Postolache T.T. Intranasal immune challenge induces sex-dependent depressive-like behavior and cytokine expression in the brain. Neuropsychopharmacology 2008, 33(5):1038-1048.
70. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 1987, 93:358-364.
71. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 1996, 711:164-174.